Dec 31, 2016

Neurocrine Biosciences Q4 2016 Earnings Report

EPS
-$0.51
Previous year: -$0.34
+50.0%
Cash and Equivalents
$83.3M
Previous year: $74.2M
+12.2%
Free Cash Flow
-$107M
Total Assets
$365M
Previous year: $475M
-23.1%

Neurocrine Biosciences

Neurocrine Biosciences